Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Bionter logo — Revolutionizing analytical testing to benefit people's healt...

Bionter

Revolutionizing analytical testing to benefit people's health

Founded 2020 Switzerland Basel, Switzerland 5 employees Seed Total: $3.00M Health Care, Pharmaceutical

General Information

Company Name Bionter
Founded Year 2020
Location Switzerland Basel, Switzerland
Employees 5
Industries Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Bionter. To contact Bionter, visit bionter.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bionter compare?

A PDF of Bionter and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bionter soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bionter

Bionter is a Swiss-based startup founded in 2020, with a vision to revolutionize analytical testing in the healthcare and pharmaceutical industries. The company's slogan, "Revolutionizing analytical testing to benefit people's health," reflects its commitment to making a positive impact on people's well-being. Bionter's focus on particle testing is of great significance as it addresses crucial aspects of patient safety and is integral to various stages of pharmaceutical development and manufacturing processes. The startup recently secured a noteworthy $3.00M in a Seed Round investment on 27 April 2022, with the investment coming from Dynamk Capital. This funding is a significant milestone for Bionter, signifying investor confidence in the company's potential to innovate and disrupt the analytical testing landscape. This financial backing will likely propel Bionter's efforts to further develop its product family and expand its market reach. In summary, Bionter's strategic focus on addressing critical needs in healthcare and pharmaceutical industries, combined with its recent successful funding round, positions the company as a promising player in the analytical testing sector. With its innovative approach and support from investors such as Dynamk Capital, Bionter is poised to make a meaningful difference in the health and well-being of individuals.

Business keywords: analytical testing, particle testing, patient safety, pharmaceutical industry, stability testing, drug formulation, process development, health innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $3.00M 1
Dynamk Capital
Dynamk Capital
27 Apr 2022

Bionter Alternatives & Competitors

View All Alternatives
Bionter vs
KABS Laboratories Inc.
KABS Laboratories Inc. Canada

One product: Commitment.

91 employees
Biotechnology, Health Care
Bionter vs
HAPILA GmbH
HAPILA GmbH

innovation and experience

Seed
12 employees
Biotechnology, Health Care
Bionter vs
ARx, LLC
ARx, LLC United States

Patient-friendly, alternative drug delivery systems through Oral Thin Films and Transdermal Patches.

55 employees
Health Care, Manufacturing
View all alternatives

FAQ About Bionter

Revolutionizing analytical testing to benefit people's health
Bionter was founded in 2020.
Bionter is headquartered in Basel, Switzerland.
Bionter operates in Health Care and Pharmaceutical. Its work centres on analytical testing, particle testing, patient safety and pharmaceutical industry.
Bionter has approximately 5 employees.
Bionter has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Seed.
Top alternatives and competitors to Bionter include KABS Laboratories Inc., HAPILA GmbH, ARx, LLC, Hangzhou Just Biotherapeutics (Just China), Ardena. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bionter and KABS Laboratories Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bionter, https://bouncewatch.com/company/bionter, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes